Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ginsberg

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Staging classification committeeR Ginsberg, J Cox, M Green, et al.
Medical Teacher|February 1, 2014
Improving staff-student relations: effects of a humanistic medicine programmeS M Plaut, L Walker-Bartnick, L Helman, et al.
Cancer Research|June 15, 1993
Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes)J W Cowens, P J Creaven, W R Greco, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 2000
Chest wall resection for locally recurrent breast cancer: is it worthwhile?R J Downey, V Rusch, F I Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patientsP Ruffie, R Feld, S Minkin, et al.
Cancer Journal (Sudbury, Mass.)|November 9, 2000
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancerK E Rosenzweig, B Mychalczak, Z Fuks, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1991
Is there ever a role for salvage operations in limited small-cell lung cancer?F A Shepherd, R Ginsberg, G A Patterson, et al.
The Journal of Infectious Diseases|November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 TeamR H Haubrich, C Flexner, M M Lederman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1997
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancerJ Armstrong, A Raben, M Zelefsky, et al.
Cancer|November 1, 1984
Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study GroupM H Gail, R T Eagan, R Feld, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Staging classification committeeR Ginsberg, J Cox, M Green, et al.
Medical Teacher|February 1, 2014
Improving staff-student relations: effects of a humanistic medicine programmeS M Plaut, L Walker-Bartnick, L Helman, et al.
Cancer Research|June 15, 1993
Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes)J W Cowens, P J Creaven, W R Greco, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 2000
Chest wall resection for locally recurrent breast cancer: is it worthwhile?R J Downey, V Rusch, F I Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patientsP Ruffie, R Feld, S Minkin, et al.
Cancer Journal (Sudbury, Mass.)|November 9, 2000
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancerK E Rosenzweig, B Mychalczak, Z Fuks, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1991
Is there ever a role for salvage operations in limited small-cell lung cancer?F A Shepherd, R Ginsberg, G A Patterson, et al.
The Journal of Infectious Diseases|November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 TeamR H Haubrich, C Flexner, M M Lederman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1997
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancerJ Armstrong, A Raben, M Zelefsky, et al.
Cancer|November 1, 1984
Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study GroupM H Gail, R T Eagan, R Feld, et al.
Pageof 8